Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas R Lenze

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Oral Oncology|February 9, 2019
Travel time to provider is associated with advanced stage at diagnosis among low income head and neck squamous cell carcinoma patients in North CarolinaDouglas R Farquhar, Maheer M Masood, Nicholas R Lenze, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 8, 2022
Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care TherapyAlexander T Murr, Nicholas R Lenze, Jared M Weiss, et al.
The Laryngoscope|November 10, 2020
Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer OutcomesNicholas R Lenze, Douglas Farquhar, Siddharth Sheth, et al.
Oral Oncology|June 23, 2021
Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinomaNicholas R Lenze, Douglas R Farquhar, Siddharth Sheth, et al.
Head & Neck|July 4, 2020
Access to preventive care services and stage at diagnosis in head and neck cancerDouglas R Farquhar, Nicholas R Lenze, Maheer M Masood, et al.
Translational Cancer Research|October 21, 2024
Comparison of surgical margins and adjuvant therapy for head and neck cancer by hospital typeDouglas R Farquhar, Nicholas R Lenze, Jason Tasoulas, et al.
Head & Neck|September 11, 2020
Age and risk of recurrence in oral tongue squamous cell carcinoma: Systematic reviewNicholas R Lenze, Douglas R Farquhar, Christina Dorismond, et al.
Head & Neck|September 28, 2023
Effect of distance of treatment center on survival for HPV-negative head and neck cancer patientsDouglas R Farquhar, Maheer M Masood, Nicholas R Lenze, et al.
Head & Neck|January 19, 2022
Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patientsMarc A Emerson, Douglas R Farquhar, Nicholas R Lenze, et al.
Cancer Medicine|May 2, 2021
The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCCJason Tasoulas, Nicholas R Lenze, Douglas Farquhar, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Oral Oncology|February 9, 2019
Travel time to provider is associated with advanced stage at diagnosis among low income head and neck squamous cell carcinoma patients in North CarolinaDouglas R Farquhar, Maheer M Masood, Nicholas R Lenze, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 8, 2022
Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care TherapyAlexander T Murr, Nicholas R Lenze, Jared M Weiss, et al.
The Laryngoscope|November 10, 2020
Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer OutcomesNicholas R Lenze, Douglas Farquhar, Siddharth Sheth, et al.
Oral Oncology|June 23, 2021
Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinomaNicholas R Lenze, Douglas R Farquhar, Siddharth Sheth, et al.
Head & Neck|July 4, 2020
Access to preventive care services and stage at diagnosis in head and neck cancerDouglas R Farquhar, Nicholas R Lenze, Maheer M Masood, et al.
Translational Cancer Research|October 21, 2024
Comparison of surgical margins and adjuvant therapy for head and neck cancer by hospital typeDouglas R Farquhar, Nicholas R Lenze, Jason Tasoulas, et al.
Head & Neck|September 11, 2020
Age and risk of recurrence in oral tongue squamous cell carcinoma: Systematic reviewNicholas R Lenze, Douglas R Farquhar, Christina Dorismond, et al.
Head & Neck|September 28, 2023
Effect of distance of treatment center on survival for HPV-negative head and neck cancer patientsDouglas R Farquhar, Maheer M Masood, Nicholas R Lenze, et al.
Head & Neck|January 19, 2022
Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patientsMarc A Emerson, Douglas R Farquhar, Nicholas R Lenze, et al.
Cancer Medicine|May 2, 2021
The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCCJason Tasoulas, Nicholas R Lenze, Douglas Farquhar, et al.
Pageof 6